Skip to main content

MitoTox™ Complex V OXPHOS Activity Assay Kit (ab109907) is designed for testing the direct inhibitory effect of compounds on Complex V activity in only 4 hours.

Be the first to review this product! Submit a review

Images

Functional Studies - MitoTox™ Complex V OXPHOS Activity Assay Kit (AB109907), expandable thumbnail
  • Functional Studies - MitoTox™ Complex V OXPHOS Activity Assay Kit (AB109907), expandable thumbnail

Publications

Key facts

Detection method

Colorimetric

Sample types

Inhibitor compounds

Assay type

Direct

Reactive species

Rat, Cow, Human

Assay time

4h

Recommended products

MitoTox™ Complex V OXPHOS Activity Assay Kit (ab109907) is designed for testing the direct inhibitory effect of compounds on Complex V activity in only 4 hours.

Key facts

Detection method

Colorimetric

Sample types

Inhibitor compounds

Assay type

Direct

Reactive species

Rat, Cow, Human

Assay time

4h

Assay Platform

Microplate reader

Storage

Shipped at conditions

Dry Ice

Appropriate short-term storage conditions

Multi

Appropriate long-term storage conditions

Multi

Storage information

Please refer to protocols

Notes

MitoTox™ Complex V OXPHOS Activity Assay Kit (ab109907) is designed for testing the direct inhibitory effect of compounds on Complex V activity in only 4 hours. Complex V extracted from the provided bovine heart mitochondria (a rich source of Complex V) is immunocaptured by specific antibodies on the plate. Complex V activity can be observed as decrease in absorbance at OD 340 nm. The intra-assay and inter-assay variation of this assay are both < 10%.

Inhibitory effects of compounds on Complex I activity can be tested in two different ways: 1. Screening format, where up to 23 compounds can be tested at a single concentration in triplicate; 2. Dose response (IC50) format, where two compounds known to affect Complex V activity can be tested at 11 different data points in triplicate.

Testing for mitochondrial function has become a key aspect of drug discovery. Mitochondria can be affected by drug treatment, resulting into cardio- and hepatotoxic side effects that can lead to drug withdrawal from the market. Therefore, there is increasing emphasis on testing the impact on mitochondria early on in the drug development process to reduce failure rates during preclinical and clinical phases.

Store Phospholipids, Bovine heart mitochondria and Activity Buffer at -80°C. Store all other components at 4°C.**Related products**Review the , or the full to learn about more assays for metabolites, metabolic enzymes, mitochondrial function, and oxidative stress, and also how to assay metabolic function in live cells using your plate reader.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

Complex V commonly called ATP synthase plays an important role in cellular energy production. This enzyme complex exists in the inner mitochondrial membrane and is approximately 600 kDa in size. Complex V facilitates the conversion of ADP and inorganic phosphate into ATP during oxidative phosphorylation. It consists of multiple subunits including Fo and F1 components where Fo functions as a proton channel while F1 performs ATP synthesis. Complex V is ubiquitously expressed across various tissues reflecting its essential role in energy generation.

Biological function summary

Complex V is important for maintaining cellular energy homeostasis by generating ATP the cell's energy currency. It operates as part of the mitochondrial respiratory chain complex essential for efficient energy transfer and storage. This complex plays a significant role in cellular metabolism by linking the electrochemical gradient formed by protons across the inner mitochondrial membrane to the mechanical rotation of its subunits leading to ATP formation. The ATP synthase products are imperative for processes demanding high energy such as muscle contraction and biosynthetic pathways.

Pathways

Complex V integrates into major metabolic routes primarily oxidative phosphorylation and the broader mitochondrial electron transport chain. It works in conjunction with complexes I to IV facilitating energy conversion via a proton gradient and ATP generation. Complex V's role complements proteins such as cytochrome c and ubiquinone which shuttle electrons within the electron transport chain ensuring a seamless energy production process essential for aerobic respiration.

Associated diseases and disorders

Complex V dysfunction can cause mitochondrial diseases and disorders related to energy metabolism including Leigh syndrome and mitochondrial myopathy. These conditions often result from mutations in the ATP synthase subunits leading to impaired ATP production and altered cellular functions. Additional related proteins in these diseases include NADH dehydrogenase and succinate dehydrogenase which when dysfunctional further contribute to defects in the electron transport chain compounding the energy production challenges in affected individuals.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Functional Studies - MitoTox™ Complex V OXPHOS Activity Assay Kit (ab109907), expandable thumbnail

    Functional Studies - MitoTox™ Complex V OXPHOS Activity Assay Kit (ab109907)

    Dose response curve for aurovertin, a non-competitive inhibitor of Complex V.

  • Functional Studies - MitoTox™ Complex V OXPHOS Activity Assay Kit (ab109907), expandable thumbnail

    Functional Studies - MitoTox™ Complex V OXPHOS Activity Assay Kit (ab109907)

    Typical dose response curve for oligomycin. Assay was performed following the Dose Response Assay Procedure using oligomycin, a well known Complex V inhibitor. Oligomycin was prepared in DMSO to generate a 10 mM stock. Starting with a 50 μM final concentration in well, 1:10 serial dilutions of oligomycin were generated.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com